Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_assertion type Assertion NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_head.
- NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_assertion description "[The agreement of clinical observations and in vitro findings, and the possibility to identify CPS1D patients who might benefit from specific treatment with NAG analogues because they exhibit reduced affinity for NAG highlight the value of this novel CPS1 expression/purification system.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_provenance.
- NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_assertion evidence source_evidence_curated NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_provenance.
- NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_assertion SIO_000772 20578160 NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_provenance.
- NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_assertion wasDerivedFrom uniprot-20150221 NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_provenance.
- NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_assertion wasGeneratedBy ECO_0000218 NP2226.RAU7wCS8IP_fG3ZlPBpuz3JaUh1SPO69Ue8YonowgKz7M130_provenance.